•
Sep 30, 2020

Merit Medical Q3 2020 Earnings Report

Merit Medical's financial performance remained stable with a slight revenue increase and improved profitability, driven by expense control and strategic initiatives.

Key Takeaways

Merit Medical reported a slight increase in worldwide revenue for Q3 2020, alongside significant growth in non-GAAP operating profit and EPS. The company is focused on enhancing efficiency and is on track with its plan to consolidate facilities and move production lines.

Worldwide revenue increased by 0.4% to $244.0 million compared to Q3 2019.

Non-GAAP EPS increased to $0.42, compared to $0.28 in Q3 2019.

GAAP operating margin improved to 0.0% from (1.2)% in Q3 2019.

The company is on track to complete the movement of more than 14 production lines and consolidate several facilities before year end.

Total Revenue
$244M
Previous year: $243M
+0.4%
EPS
$0.42
Previous year: $0.28
+50.0%
Non-GAAP Operating Margin
15%
Previous year: 9.2%
+63.0%
Gross Profit
$102M
Previous year: $104M
-2.0%
Cash and Equivalents
$44.6M
Previous year: $37.3M
+19.4%
Free Cash Flow
$45.4M
Previous year: -$6.93M
-754.3%
Total Assets
$1.67B
Previous year: $1.76B
-5.2%

Merit Medical

Merit Medical

Merit Medical Revenue by Segment

Forward Guidance

Merit Medical updated its fiscal year 2020 revenue guidance. They estimate net revenue to be in the range of $950.0 million to $959.0 million and non-GAAP net income to be in the range of $85.5 million to $88.5 million.

Revenue & Expenses

Visualization of income flow from segment revenue to net income